Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

COVID-19 may cause hair loss due to infection stress or treatments.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Skin organoids can model tuberculosis infection and help test treatments.

Reinfection patients had more physical complications, while initial infection patients had more mental health issues.

COVID-19 may trigger alopecia areata, but more research is needed.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Removing breast implants resolved the patient's symptoms.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Insulin resistance linked to obesity may increase COVID-19 severity.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Hair loss doesn't affect COVID-19 severity.

High PMP 22 levels in type 2 diabetes patients may cause hearing loss.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

The random forest model effectively helps diagnose COVID-19 using key factors like age and symptoms.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

PCOS women with COVID-19 have higher cardiometabolic risks.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.